These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
623 related articles for article (PubMed ID: 27771374)
1. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma. McGregor SM; McElherne J; Minor A; Keller-Ramey J; Dunning R; Husain AN; Vigneswaran W; Fitzpatrick C; Krausz T Hum Pathol; 2017 Feb; 60():86-94. PubMed ID: 27771374 [TBL] [Abstract][Full Text] [Related]
2. Utility of BAP1 Immunohistochemistry and p16 (CDKN2A) FISH in the Diagnosis of Malignant Mesothelioma in Effusion Cytology Specimens. Hwang HC; Sheffield BS; Rodriguez S; Thompson K; Tse CH; Gown AM; Churg A Am J Surg Pathol; 2016 Jan; 40(1):120-6. PubMed ID: 26448191 [TBL] [Abstract][Full Text] [Related]
3. BAP1 immunohistochemistry and p16 FISH results in combination provide higher confidence in malignant pleural mesothelioma diagnosis: ROC analysis of the two tests. Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Iwasaki A; Okamoto T; Oda Y; Honda H; Nabeshima K Pathol Int; 2016 Oct; 66(10):563-570. PubMed ID: 27614970 [TBL] [Abstract][Full Text] [Related]
4. Usefulness of p16/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. Wu D; Hiroshima K; Yusa T; Ozaki D; Koh E; Sekine Y; Matsumoto S; Nabeshima K; Sato A; Tsujimura T; Yamakawa H; Tada Y; Shimada H; Tagawa M Ann Diagn Pathol; 2017 Feb; 26():31-37. PubMed ID: 28038708 [TBL] [Abstract][Full Text] [Related]
5. Contribution of BAP1 loss and p16 (CDKN2A) deletion analysis to the definitive diagnosis of mesothelioma in effusion cytology. Aydogdu G; Özekinci S Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):10001-10007. PubMed ID: 37916370 [TBL] [Abstract][Full Text] [Related]
6. BAP1 loss is unusual in well-differentiated papillary mesothelioma and may predict development of malignant mesothelioma. Lee HE; Molina JR; Sukov WR; Roden AC; Yi ES Hum Pathol; 2018 Sep; 79():168-176. PubMed ID: 29763720 [TBL] [Abstract][Full Text] [Related]
7. BAP1 immunohistochemistry and p16 FISH to separate benign from malignant mesothelial proliferations. Sheffield BS; Hwang HC; Lee AF; Thompson K; Rodriguez S; Tse CH; Gown AM; Churg A Am J Surg Pathol; 2015 Jul; 39(7):977-82. PubMed ID: 25634745 [TBL] [Abstract][Full Text] [Related]
8. Sarcomatoid Mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1. Zaleski M; Kalhor N; Fujimoto J; Wistuba I; Moran CA Pathol Res Pract; 2020 Dec; 216(12):153267. PubMed ID: 33176261 [TBL] [Abstract][Full Text] [Related]
9. The epithelioid BAP1-negative and p16-positive phenotype predicts prolonged survival in pleural mesothelioma. Chou A; Toon CW; Clarkson A; Sheen A; Sioson L; Gill AJ Histopathology; 2018 Feb; 72(3):509-515. PubMed ID: 28889523 [TBL] [Abstract][Full Text] [Related]
10. BAP1 Immunohistochemistry and p16 FISH in the Diagnosis of Sarcomatous and Desmoplastic Mesotheliomas. Hwang HC; Pyott S; Rodriguez S; Cindric A; Carr A; Michelsen C; Thompson K; Tse CH; Gown AM; Churg A Am J Surg Pathol; 2016 May; 40(5):714-8. PubMed ID: 26900815 [TBL] [Abstract][Full Text] [Related]
11. Genomic Deletion of Sarun KH; Lee K; Williams M; Wright CM; Clarke CJ; Cheng NC; Takahashi K; Cheng YY Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30301262 [TBL] [Abstract][Full Text] [Related]
12. A combination of MTAP and BAP1 immunohistochemistry in pleural effusion cytology for the diagnosis of mesothelioma. Kinoshita Y; Hida T; Hamasaki M; Matsumoto S; Sato A; Tsujimura T; Kawahara K; Hiroshima K; Oda Y; Nabeshima K Cancer Cytopathol; 2018 Jan; 126(1):54-63. PubMed ID: 29053210 [TBL] [Abstract][Full Text] [Related]
13. Loss of BAP1 Expression in Atypical Mesothelial Proliferations Helps to Predict Malignant Mesothelioma. Pillappa R; Maleszewski JJ; Sukov WR; Bedroske PP; Greipp PT; Boland JM; Yi ES; Peikert T; Aubry MC; Roden AC Am J Surg Pathol; 2018 Feb; 42(2):256-263. PubMed ID: 29076876 [TBL] [Abstract][Full Text] [Related]
14. Testing for BAP1 loss and CDKN2A/p16 homozygous deletion improves the accurate diagnosis of mesothelial proliferations in effusion cytology. Chevrier M; Monaco SE; Jerome JA; Galateau-Salle F; Churg A; Dacic S Cancer Cytopathol; 2020 Dec; 128(12):939-947. PubMed ID: 32678499 [TBL] [Abstract][Full Text] [Related]
15. Hemizygous loss of NF2 detected by fluorescence in situ hybridization is useful for the diagnosis of malignant pleural mesothelioma. Kinoshita Y; Hamasaki M; Yoshimura M; Matsumoto S; Iwasaki A; Nabeshima K Mod Pathol; 2020 Feb; 33(2):235-244. PubMed ID: 31231129 [TBL] [Abstract][Full Text] [Related]
16. Fluorescence in situ hybridization (FISH) provides estimates of minute and interstitial BAP1, CDKN2A, and NF2 gene deletions in peritoneal mesothelioma. Brich S; Bozzi F; Perrone F; Tamborini E; Cabras AD; Deraco M; Stacchiotti S; Dagrada GP; Pilotti S Mod Pathol; 2020 Feb; 33(2):217-227. PubMed ID: 31570769 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of methylthioadenosine phosphorylase and BRCA-associated protein 1 immunohistochemistry in the diagnosis of malignant mesothelioma in effusion cytology specimens. Berg KB; Churg AM; Cheung S; Dacic S Cancer Cytopathol; 2020 Feb; 128(2):126-132. PubMed ID: 31821740 [TBL] [Abstract][Full Text] [Related]
19. BAP1 Immunostain and CDKN2A (p16) FISH Analysis: Clinical Applicability for the Diagnosis of Malignant Mesothelioma in Effusions. Walts AE; Hiroshima K; McGregor SM; Wu D; Husain AN; Marchevsky AM Diagn Cytopathol; 2016 Jul; 44(7):599-606. PubMed ID: 27121152 [TBL] [Abstract][Full Text] [Related]
20. The significance of BAP1 and MTAP/CDKN2A expression in well-differentiated papillary mesothelial tumour: a series of 21 cases and a review of the literature. Hassan A; Prabhakaran S; Pulford E; Hocking AJ; Godbolt D; Ziad F; Pandita A; Wessels A; Hussey M; Russell PA; Klebe S Pathology; 2024 Aug; 56(5):662-670. PubMed ID: 38789301 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]